A3AR agonist 2

• UNSPSC Description:

  A3AR agonist 2 (Compound 19) a selective A3AR agonist (Ki: 22.1 nM). A3AR agonist 2 stimulates β-arrestin2 recruitment, with EC50 value of 4.36 nM. A3AR agonist 2 can be used for research of inflammatory diseases, ischemia, cancer, neuropathic pain, liver diseases, and other chronic conditions[1]. A3AR agonist 2 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

• Target Antigen:

  Adenosine Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Cancer; Inflammation/Immunology; Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/a3ar-agonist-2.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CNC([C@]12[C@@H](O)[C@@H](O)[C@H](N3C=NC4=C3N=C(C#CC5=CC=CC6=C5)N=C4NCCC7=CC(OC/C=C\CO6)=C(OC)C=C7)[C@H]1C2)=O

• Molecular Weight:

  622.67

• References & Citations:

  [1]Dilip K. Tosh, et al. First Potent Macrocyclic A3 Adenosine Receptor Agonists Reveal G-Protein and 尾-Arrestin2 Signaling Preferences. ACS Pharmacol. Transl. Sci. 2023.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported